Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
‘And then we saw the little head.’ Scientists witness rare sperm whale birth - 2Meet the Stars of the Feline World: Well known Pet Feline Varieties
- 3Private sector revives the climate disaster database Trump tried to squash
- 4NASA's Artemis 2 pilot Victor Glover listens to 'Whitey on the Moon' every Monday. This is why.
- 5Vote in favor of your favored spot to peruse
- How to disinfect if the stomach bug hits your home
- Consumer outlook on UK economy falls to two-year low
- Global measles cases drop 71% in 24 years as vaccination coverage improves, WHO says
- 6 Web-based Staple Help You Can Trust
- The Tiny Channel Island With 65 Residents That Chefs And Foodies Go Out Of Their Way To Visit
- With Obamacare premium hikes, more people opting for no coverage or cheaper plans
- Surge of off‑lease electric vehicles expected to drive down used EV prices
- Consume Fat Quick: 10 Demonstrated Activities for Ideal Outcomes
- What's Your #1 Pizza Beating Mix?
